Increased Risk of Severe Infections in Cancer Patients Treated With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Meta-Analysis
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s87298
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2015
Authors
Publisher
Informa UK Limited